STS
TAK icon

SG Trading Solutions’s Takeda Pharmaceutical TAK Stock Holding History

SG Trading Solutions’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$682K Buy
+43,758
New +$626K 0.16% 124

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SG Trading Solutions's TAK Position: Q4 2025 in Review

SG Trading Solutions opened a new position in Takeda Pharmaceutical (TAK) in Q4 2025: 43,758 shares worth $682K. The stake represents 0.16% of the portfolio and ranks #124 among its holdings.

349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • SG Trading Solutions held 43,758 shares of Takeda Pharmaceutical worth $682K as of Q4 2025.
  • Takeda Pharmaceutical was a new SG Trading Solutions position in Q4 2025.
  • Takeda Pharmaceutical made up 0.16% of SG Trading Solutions's portfolio in Q4 2025, its #124 holding.
  • 349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on SG Trading Solutions's 13F filing for Q4 2025, filed 24 Feb 2026.